Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22837830 | 0.71 | HTR2A (0.43) | HTR2AHTR2CL3MBTL3L3MBTL1 | |
| SCHEMBL20598412 | 0.69 | USP5 (0.56) | HTR2AHTR2C | |
| SCHEMBL18828725 | 0.68 | L3MBTL3 (0.36) | L3MBTL3L3MBTL1 | |
| SCHEMBL3780104 | 0.67 | CYP1A2 (0.32) | HTR2AHTR2CL3MBTL1 | |
| SCHEMBL578509 | 0.66 | MCHR1 (0.48) | HTR2AHTR2C | |
| SCHEMBL578464 | 0.66 | MCHR1 (0.48) | HTR2AHTR2C | |
| SCHEMBL2544388 | 0.66 | MCHR1 (0.48) | HTR2AHTR2C | |
| SCHEMBL17271879 | 0.66 | L3MBTL3 (0.84) | L3MBTL3L3MBTL1 | |
| SCHEMBL3774487 | 0.65 | ATM (0.36) | HTR2AHTR2C | |
| SCHEMBL23057104 | 0.64 | HRH3 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017114497-A1 | IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY | NOVARTIS AG (CH) | 2017-07-06 | — | — | WO | disclosed |